University · founded 1911
Anderson University - South Carolina
Anderson, United States · andersonuniversity.edu
- Citations, last 5 years
- 1 240
- Works, last 5 years
- 169
- h-index
- 34
- Scientists listed
- 11
- Grants since 2016
- 1 743
Grants received
2019–2023 · research · R01
Regulation of RNA polymerase II pausing and directionality by ATP-dependent chromatin remodelers
Blaine Bartholomew · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Use of Patient-Reported Outcomes in Understanding Symptomatic Adverse Events in Early-Phase Trials of Combination Treatments that Include Immune Checkpoint Inhibitors and Targeted Therapy
Goldy C George · Anderson University - South Carolina · funded by National Institutes of Health
2019–2025 · cooperative agreement · UG1
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP) UG1
Kelly K Hunt · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
INVESTIGATING TUMOR INITIATION AND INVASION IN PREMALIGNANT BREAST CANCER WITH SPATIAL SINGLE CELL GENOMICS
Nicholas Navin · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · program · P50
The University of Texas MD Anderson Cancer Center SPORE in Melanoma
Patrick Hwu · Anderson University - South Carolina · funded by National Institutes of Health
2019–2020 · career development · K01
Identifying Risk Factors for Antibiotic Resistance via Integration of Epidemiology and Metagenomics
Jessica Rhea Galloway-Pena · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Therapeutic strategies against EGFR exon 20 mutant lung cancer
John V. Heymach · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · cooperative agreement · UG1
iCAN-PREVENT: MD Anderson International Cancer Prevention Clinical Trial Consortium
Powel H Brown · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
T Cell Immunity Of COVID19: Developing Biomarker And Therapeutic Strategies
Cassian Yee · Anderson University - South Carolina · funded by National Institutes of Health
2019–2021 · research · R21
Molecularly targeted photothermal ablation to enhance the therapeutic efficacy of immunomodulatory therapies in hepatocellular carcinoma
Rahul Anil Sheth · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R21
Mitigating High Grade Radiation-Induced Lymphopenia through Pretreatment Autologous Lymphocyte Infusion
Gheath Al-Atrash · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · cooperative agreement · U01
Building a Diverse Biomedical Workforce Through Communication Across Difference
Carrie A. Cameron · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Development of Long non-coding RNA-directed Target Therapy for Triple-Negative Breast Cancer
Chunru Lin · Anderson University - South Carolina · funded by National Institutes of Health
2019–2022 · fellowship · F32
Identifying the role of Ntrk1 in immunosuppression in Kras/p53 mutant lung cancer
Jessica Konen · Anderson University - South Carolina · funded by National Institutes of Health
2019–2025 · career development · K08
Developing a Decision Tool for Chemotherapy in Older Women with Early Stage Breast Cancer
Meghan Sri Karuturi · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
DELINEATING THE EVOLUTION AND ECOLOGY OF CHEMORESISTANCE IN BREAST CANCER WITH SINGLE CELL GENOMICS
Nicholas Navin · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Rigorous and reproducible mutational analysis of the urinary exosomal DNA
Colin P.N. Dinney · Anderson University - South Carolina · funded by National Institutes of Health
2019–2026 · research · R35
Inducible epithelial resistance: a program investigating mechanisms to protect against acute and chronic complications of pneumonia
Scott E. Evans · Anderson University - South Carolina · funded by National Institutes of Health
2019–2025 · research · R01
DELINEATING THE EVOLUTION AND ECOLOGY OF CHEMORESISTANCE IN BREAST CANCER WITH SINGLE CELL GENOMICS
Nicholas Navin · Anderson University - South Carolina · funded by National Institutes of Health
2019–2021 · contract · N01
OTHER FUNCTIONS - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
Powel Brown · Anderson University - South Carolina · funded by National Institutes of Health
2019–2025 · research · R01
A Novel Hsp90 Inhibitor as a Chemo and Radiosensitizer in Adults with Glioblastoma
Vinay K Puduvalli · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · cooperative agreement · UG1
iCAN-PREVENT: MD Anderson International Cancer Prevention Clinical Trial Consortium
Powel H Brown · Anderson University - South Carolina · funded by National Institutes of Health
2019–2021 · research · R03
Genomic Stratification and Targeting of HPV+ Cancer
Curtis Pickering · Anderson University - South Carolina · funded by National Institutes of Health
2019–2023 · research · R01
A novel natural history study of medullary thyroid carcinoma: Incorporating the patient perspective to inform advanced disease management
Elizabeth Gardner Grubbs · Anderson University - South Carolina · funded by U.S. Food and Drug Administration
2019–2022 · fellowship · F31
The Role of HIF2-Induced Wnt5a in Small Intestine Regeneration after Radiation Injury
Carolina Jannet Garcia Garcia · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Anatomical Modeling to Improve the Precision of Image Guided Liver Ablation
Kristy Brock · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · cooperative agreement · U01
Building a Diverse Biomedical Workforce Through Communication Across Difference
Carrie A. Cameron · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Translating Intestinal Radioprotection by EGLN Inhibition to Improve Clinical Outcomes in Unresectable Pancreatic Cancer
Cullen Mitsuo Taniguchi · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Targeting mitochondrial complex I in acute lymphoblastic leukemia
Marina Y Konopleva · Anderson University - South Carolina · funded by National Institutes of Health
2019–2021 · research · R21
Targeting Tankyrases to Mitigate Immunosuppression and Enhance Cancer Immunotherapy
Steven Hsesheng Lin · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
The molecular and immune evolution in the progression of lung neoplasia to invasive adenocarcinoma
Jianjun Zhang · Anderson University - South Carolina · funded by National Institutes of Health
2019–2026 · research · R01
Development of functional magnetic resonance imaging-guided adaptive radiotherapy for head and neck cancer patients using novel MR-Linac device
John Paul Christodouleas · Anderson University - South Carolina · funded by National Institutes of Health
2019–2026 · cooperative agreement · UG1
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAPS) UG1
Chelsea Camille Pinnix · Anderson University - South Carolina · funded by National Institutes of Health
2019–2026 · research · R35
Inducible epithelial resistance: a program investigating mechanisms to protect against acute and chronic complications of pneumonia
Scott E. Evans · Anderson University - South Carolina · funded by National Institutes of Health
2019–2027 · research · R01
Ph1/2 Study of the Imipridone ONC201 for Treatment of AML IND125,203 (12/23/2014)
Michael Andreeff · Anderson University - South Carolina · funded by U.S. Food and Drug Administration
2019–2031 · cooperative agreement · UG1
iCAN PREVENT: MD Anderson International Cancer Prevention Clinical Trials Consortium
Eduardo Vilar Sanchez · Anderson University - South Carolina · funded by National Institutes of Health
2019–2025 · research · R01
Use of Patient-Reported Outcomes in Understanding Symptomatic Adverse Events in Early-Phase Trials of Combination Treatments that Include Immune Checkpoint Inhibitors and Targeted Therapy
Goldy C George · Anderson University - South Carolina · funded by National Institutes of Health
2019–2025 · program · P50
Project 2: Targeting STAT3 to Prevent Colorectal Cancer (CRC) in Hereditary Syndromes and Inflammatory Bowel Disease
David John Tweardy · Anderson University - South Carolina · funded by National Institutes of Health
2019–2025 · program · P50
Core 1: Biospecimen and Pathology Core
Dipen M. Maru · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · program · P50
Project 2: Targeting STAT3 with an Oral Small Molecule to Treat HCC
David John Tweardy · Anderson University - South Carolina · funded by National Institutes of Health
